Skip to main content

Table 3 Patient-reported usage of current acute treatment in insufficient responders/sufficient responders to acute treatment for migraine

From: Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme

  Insufficient responders (N = 227) Sufficient responders (N = 311) Total (N = 538)
Time of administration of acute therapy, n (%)*
 At first sign of a migraine 49 (23.0) 94 (31.1) 143 (27.8)
 When/after the pain starts 164 (77.0) 208 (68.9) 372 (72.2)
Continue using currently prescribed acute medication, n (%)*
 Definitely yes 48 (21.6) 132 (43.1) 180 (34.1)
 Probably yes 121 (54.5) 147 (48.0) 268 (50.8)
 Do not know 43 (19.4) 24 (7.8) 67 (12.7)
 Probably not 10 (4.5) 2 (0.7) 12 (2.3)
 Definitely not 0 1 (0.3) 1 (0.2)
Ever needs to take extra doses to relieve pain/migraine symptoms, n (%)* 85 (41.1) 52 (18.7) 137 (28.2)
Number of times extra doses of a prescribed acute medication were taken for the last ten migraine attacks, mean ± SD*a 3.34 ± 2.1 2.14 ± 1.9 2.89 ± 2.1
  1. Reported data are number and percentage of patients, unless stated otherwise, with percentages calculated as proportion of non-missing data
  2. *p < 0.05 between insufficient responders and sufficient responders. For categorical measures, chi-squared or Fisher’s exact test was used. For continuous measures, t-test was used
  3. aAssessed in patients needing to take extra doses to control pain/migraine symptoms
  4. SD standard deviation